| Parkinson disease-associated cognitive impairment D Aarsland, L Batzu, GM Halliday, GJ Geurtsen, C Ballard, ... Nature Reviews Disease Primers 7 (1), 1-21, 2021 | 681 | 2021 |
| Relevance of antibodies to myelin oligodendrocyte glycoprotein in CSF of seronegative cases S Mariotto, A Gajofatto, L Batzu, R Delogu, GP Sechi, S Leoni, MI Pirastru, ... Neurology 93 (20), e1867-e1872, 2019 | 96 | 2019 |
| Neurofilament light chain serum levels reflect disease severity in MOG-Ab associated disorders S Mariotto, S Ferrari, M Gastaldi, D Franciotta, E Sechi, R Capra, ... Journal of Neurology, Neurosurgery & Psychiatry 90 (11), 1293-1296, 2019 | 48 | 2019 |
| Identifying and responding to fatigue and apathy in Parkinson’s disease: a review of current practice C Lazcano-Ocampo, YM Wan, DJ van Wamelen, L Batzu, I Boura, ... Expert review of neurotherapeutics 20 (5), 477-495, 2020 | 41 | 2020 |
| Constipation is associated with development of cognitive impairment in de novo Parkinson’s disease: a longitudinal analysis of two international cohorts V Leta, D Urso, L Batzu, D Weintraub, N Titova, D Aarsland, ... Journal of Parkinson's Disease 11 (3), 1209-1219, 2021 | 40 | 2021 |
| Viruses, parkinsonism and Parkinson’s disease: The past, present and future V Leta, D Urso, L Batzu, YH Lau, D Mathew, I Boura, V Raeder, ... Journal of Neural Transmission 129 (9), 1119-1132, 2022 | 34 | 2022 |
| Non-motor complications in late stage Parkinson’s disease: recognition, management and unmet needs K Rukavina, L Batzu, A Boogers, A Abundes-Corona, V Bruno, ... Expert Review of Neurotherapeutics 21 (3), 335-352, 2021 | 30 | 2021 |
| Plasma p-tau181, neurofilament light chain and association with cognition in Parkinson’s disease L Batzu, S Rota, A Hye, A Heslegrave, D Trivedi, LL Gibson, C Farrell, ... npj Parkinson's Disease 8 (1), 154, 2022 | 27 | 2022 |
| Cerebrospinal fluid progranulin is associated with increased cortical thickness in early stages of Alzheimer's disease L Batzu, E Westman, JB Pereira, ... Neurobiology of aging 88, 61-70, 2020 | 24 | 2020 |
| Cancer-related Wernicke-Korsakoff syndrome GP Sechi, L Batzu, L Agrò, C Fois The Lancet Oncology 17 (6), e221-e222, 2016 | 19 | 2016 |
| Late presentation of NMOSD as rapidly progressive leukoencephalopathy with atypical clinical and radiological findings E Sechi, A Addis, L Batzu, S Mariotto, S Ferrari, M Conti, GP Sechi Multiple Sclerosis Journal 24 (5), 685-688, 2018 | 16 | 2018 |
| Parkinson’s disease: Personalized pathway of care for device-aided therapies (DAT) and the role of continuous objective monitoring (COM) using wearable sensors V Metta, L Batzu, V Leta, D Trivedi, A Powdleska, KR Mridula, P Kukle, ... Journal of Personalized Medicine 11 (7), 680, 2021 | 13 | 2021 |
| Clinical trajectories and biomarkers for weight variability in early Parkinson’s disease D Urso, DJ van Wamelen, L Batzu, V Leta, J Staunton, JA Pineda-Pardo, ... npj Parkinson's Disease 8 (1), 95, 2022 | 11 | 2022 |
| ‘Dopamine agonist Phobia’in Parkinson’s disease: when does it matter? Implications for non-motor symptoms and personalized medicine S Rota, I Boura, L Batzu, N Titova, P Jenner, C Falup-Pecurariu, ... Expert Review of Neurotherapeutics 20 (9), 953-965, 2020 | 8 | 2020 |
| Clinical trials for cognition in Parkinson's disease: Where are we and how can we do better? E Bayram, L Batzu, B Tilley, R Gandhi, P Jagota, R Biundo, M Garon, ... Parkinsonism & Related Disorders 112, 105385, 2023 | 7 | 2023 |
| Chaudhuri's Dashboard of Vitals in Parkinson's syndrome: an unmet need underpinned by real life clinical tests M Qamar, S Rota, L Batzu, I Subramanian, C Falup-Pecurariu, N Titova, ... Frontiers in Neurology 14, 930, 2023 | 7 | 2023 |
| Disentangling the PIGD classification for the prediction of cognitive impairment in de novo Parkinson’s disease D Urso, V Leta, L Batzu, T Yousaf, C Farrell, DJ van Wamelen, ... Journal of Neurology 269 (3), 1566-1573, 2022 | 7 | 2022 |
| Frailty in Parkinson's disease and its association with early dementia: A longitudinal study MG Borda, MU Pérez‐Zepeda, A Jaramillo-Jimenez, KR Chaudhuri, ... Parkinsonism & Related Disorders 99, 51-57, 2022 | 6 | 2022 |
| New approaches to treatments for sleep, pain and autonomic failure in Parkinson's disease-Pharmacological therapies K Rukavina, L Batzu, V Leta, KR Chaudhuri Neuropharmacology 208, 108959, 2022 | 6 | 2022 |
| The pathophysiology of sexual dysfunction in Parkinson's disease: An overview L Batzu, N Titova, KB Bhattacharyya, KR Chaudhuri International review of neurobiology 162, 21-34, 2022 | 5 | 2022 |
